The results of the research on the treatment of new crown pneumonia were published in the University of Science and Technology of China

The team of Professor Wei Haiming of the Chinese University of Science and Technology and Professor Xu Xiaoling of the Chinese University of Science and Technology Attached Hospital (Anhui Provincial Hospital) collaborated on the research results of the "Tozhu single anti-conventional treatment" to suppress the "inflammatory storm" treatment program into the "New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial 7th Edition)", as an important program to treat seriously ill patients, reduce the death rate in the country to provide scientific and technological support for China to win the epidemic prevention and control, and to provide scientific and technological support in Italy, Spain, Iran and other countries. Recently, the
study looked at the clinical efficacy of 21 patients who were the first to use toads in the Second People's Hospital of Fuyang City and the Infection Hospital attached to the Chinese University of Science and Technology. The patients ranged in age from 25 to 88. Among them, 17 cases of severe illness and 4 cases of critical illness. Fever was the first symptom, with an average body temperature of 38.8 ± 0.6 degrees Celsius. There was a 1 week of routine treatment history before the use of toad monotherapy, but the symptoms did not improve, on average, after 5.6 days all patients had different degrees of deterioration of the condition, persistent fever, hypoxemia, lung CT showed progression of lesions. Among them, 2 routine trachea intestor ventilator auxiliary ventilation, 1 case non-invasive ventilator auxiliary ventilation. On the first day after the treatment, the body temperature of all patients returned to normal and remained stable, followed by a significant relief of clinical symptoms over the next few days. Most patients have some improvement in respiratory function and reduced chest tightness. 75% of patients reduced oxygen absorption flow within 5 days, and the saturation of outer blood oxygen remained stable. 2 cases were evacuated from the ventilator within 5 days of being given to the toad mono-resistance. Inflammation indicators such as the number of exoglobin lymphocytes and C-reactive proteins mostly recover within 5 days. All patients were discharged from the hospital, and the average length of hospital stay after the use of toads was 15.1 days. There were no adverse drug reactions and secondary lung infections during treatment.
, the study reviewed the role of toads in the treatment of severe or critically ill patients with neo-crown pneumonia, and provided a new treatment strategy for patients with severe neo-crown pneumonia.
relevant paper information: